APP下载

注射用炎琥宁与α-干扰素治疗小儿上呼吸道感染的有效性和安全性系统评价

2019-09-10彭佳谭波宇宁宁

湖南中医药大学学报 2019年8期

彭佳 谭波宇 宁宁

〔摘要〕 目的 系统评价注射用炎琥宁与α-干扰素治疗小儿上呼吸道感染的有效性和安全性,为临床应用提供循证医学证据。方法 计算机检索CBM、CNKI、VIP、WanFang Data等数据库,纳入注射用炎琥宁与α-干扰素治疗小儿上呼吸道感染的随机对照试验(RCT)或半随机对照试验(qRCT),检索时间为建库至今,对符合纳入标准的研究进行质量评价,并使用Rev Man 5.3软件进行Meta分析。结果 共纳入10项研究,合计1104例患儿。Meta分析结果显示,注射用炎琥宁与α-干扰素治疗小儿呼吸系统感染可以显著提高患儿的总有效率(OR=4.99,95%CI:3.22~7.74,P<0.01),缩短退热时间(MD=-1.39,95%CI:-1.87~-0.92,P<0.01)、咳嗽消失时间(MD=-1.54,95%CI:-2.25~-0.83,P<0.01)、鼻塞流涕消失时间(MD=-1.65,95%CI:-2.35~-0.95,P<0.01)。结论 注射用炎琥宁与α-干扰素治疗小儿呼吸系统感染疗效较好,可明显缩短患儿退热时间、咳嗽消失时间、鼻塞流涕消失时间。

〔关键词〕 炎琥宁;α-干扰素;小儿呼吸系统感染;系统评价

〔中图分类号〕R272       〔文献标志码〕A    ;   〔文章编号〕doi:10.3969/j.issn.1674-070X.2019.08.023

〔Abstract〕 Objective To systematically review the effects and safety of Yanhuning and α-interferon in the treatment of respiratory infection in children, and provide evidence-based basis for clinical application. Methods The randomized controlled trails (RCTs) or semi-randomized controlled trials (qRCTs) on Yanhuning and α-interferon in the treatment of respiratory infection in children were searched in CBM, CNKI, VIP, WanFang Data from the date of their establishment to October 2017. According to the inclusion criteria, the quality for the requirements of RCT and meta-analysis were performed with Rev-Man 5.3 software. Results Totally 10 studies were enrolled,involving 1104 patients. Results of meta-analysis showedthe Yanhuning and α-interferon for injection in the treatment of children respiratory system infections can significantly improve the clinical total effective rate(OR=4.99, 95%CI: 3.22-7.74, P<0.01), shorten fever duration (MD=-1.39, 95%CI: -1.87--0.92, P<0.01), cough duration (MD=-1.54, 95%CI: -2.25- -0.83, P<0.01), runny nose duration(MD=-1.65, 95%CI: -2.35- -0.95, P<0.01). Conclusion The Yanhuning and α-interferon for injection can improve the clinical eficacy in the treatment of children respiratory system infections,and significantlyshorten fever duration, cough duration and runny nose duration.

〔Keywords〕 Yanhuning; α-interferon; children respiratory system infections; systematic review

小兒急性上呼吸道感染是儿科最常见的疾病,90%以上由病毒感染所致,包括呼吸道合胞病毒、流感病毒、副流感病毒和腺病毒,主要侵犯鼻、咽、喉,产生临床症状[1]。如不及时进行有效治疗,则可能引发心肌炎、肺炎等并发症,严重影响患儿的身体健康。α-干扰素和炎琥宁两种药物均对小儿急性上呼吸道感染有一定的效果。临床上有大量炎琥宁与α-干扰素单独或联合治疗小儿上呼吸道感染疗效比较的临床研究[2-3],但结果各异,且其存在研究设计方法质量较低、样本量较小、试验设计不统一等问题,对药物治疗效果缺乏循证医学证据。……

登录APP查看全文